TAMPA, Fla. (Legal Newsline) – A DuPage County, Illinois resident has filed a class-action lawsuit over allegations a prescription drug was contaminated with a probable human carcinogen.
Barbara Kruk, individually and on behalf of all others similarly situated, filed a complaint on Dec. 1 in the U.S. District Court for the Middle District of Florida, Tampa Division against Aurobindo Pharma LTD, Sciegen Pharmaceuticals Inc., Westminster Pharmaceuticals LLC and Walmart Inc. alleging strict product liability and other counts.
According to the complaint, Kruk purchased and ingested tablets containing adulterated Iibesartan, a drug manufactured, distributed or sold by the defendants to treat high blood pressure and diabetic nephropathy. The suit states the medications contains active pharmaceutical ingredient adulterated with N-nitrosodiethylamine, a probable human carcinogen, because of manufacturing defects originating in a facility in India.
The plaintiff alleges the defendants failed to provide adequate warnings to the medical community and the consumers that the medication was defective.
The plaintiff requests a trial by jury and seeks judgment for damages, attorney's fees, costs, pre- and post-judgment interest, and all other relief may deem just and appropriate. She is represented by John Sawin of Sawin Law Firm LTD in Chicago and others.
U.S. District Court for the Middle District of Florida, Tampa Division case number 8:18-cv-02927-WFJ-SPF